12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

6 de May de 2025

Our firm recently secured another important court victory on behalf of a software developer client in a lawsuit against a company that … Legal Protection for Developers: Compensation for Irregular Licenses

Kasznar Leonardos

24 de April de 2025

During software compliance audits, it is not uncommon for companies to claim that pirated programs were installed by external contractors or IT … Third Parties and Software Piracy: Companies Remain Legally Responsible

Kasznar Leonardos

16 de April de 2025

The Public Consultation (CP) No. 1.316/2025, which aims to initiate the review process of Collegiate Board Resolution (RDC) No. 327/2019 from the … Medicinal Cannabis Review: Public Consultation 1.316/2025 open